Shelley Margetson

Shelley currently serves as the CEO of Gadeta B.V., a company based in the Netherlands focussed on the development of innovative immunotherapies for cancer. 

She has been involved with multiple European biotechnology companies since 2001 including PanGenetics B.V. (acquired by Abbott) where she was VP of Finance, and Merus N.V. (Nasdaq: MRUS) where she held the position of CFO/COO before joining Gadeta.